Important
Updates
SMS Pharmaceuticals LimitedSMSPHARMA · Filed with the exchange
SMS Pharma filed its Business Responsibility and Sustainability Report for FY2025-26. Key initiatives include a new `1.9 Cr` CAPEX for advanced effluent treatment, commissioning a 1.3 MW rooftop solar project, and enhancing solvent recovery by 45-50%, significantly cutting hazardous waste.
Local sourcing reduced transport-related GHG emissions by ~21 tCO2e.
No comments yet. Be the first.